Are your sample vials causing problems in your HPLC analysis?
The random appearance of unknown peaks (ghost peaks), contaminant peaks, loss of sensitivity or lack of reproducibility are not uncommon in chromatography. Determining the root cause of these issues can be time-consuming and difficult to troubleshoot. In many cases, the root cause is determined to be the sample vials.
In this webinar we’ll delve into the critical role of chemically tested sample vials, ensuring accurate and reliable analytical outcomes. Discover how seemingly minor details—such as vial septum material, dimensions, and the glass surface can significantly impact your results. Our experts will guide you through real-world cases where choosing the right vial made all the difference.
Here’s what you’ll learn:
- Understand the vial characteristics that directly influence your analytical data.
- Explore Waters’ range of sample vials designed to address common challenges.
- Learn practical tips for diagnosing and preventing vial-related issues in chromatography.
Presenter: Markus Wanninger (Principal Product Manager, Waters Corporation)
Markus is the principal product manager of sample vials and plates. He has a degree in chemical engineering and long-standing experience in the pharmaceutical industry. Markus has a keen understanding of the needs of analytical HPLC laboratories, and the controls required to have certainty in results and staying in compliance. The drive to control and optimize processes enabled the Markus and the vials team to drive continuous improvement of product lines to meet the demands of todays’ laboratories. Outside his professional life Markus is a passionate photographer and an inspiring chef and pitmaster.
Presenter: Nikunj Tanna (Principal Scientist, Waters Corporation)
Nikunj Tanna is a Principal Scientist at Waters Corporation who is passionate about meeting people, making connections, and learning from every conversation. His role at Waters focuses on complete workflow solutions for quantitation of small and large molecules. These end-to-end workflows include automation, novel sample preparation and chromatographic separation approaches, followed by detection using TQ and/or HRMS platforms. In his current role, he has particular emphasis on sample preparation and automation for bioanalysis, ADME and DMPK applications. In previously roles, he lead a clinical diagnostics team at Berg LLC developing bioanalytical methods for drug candidates. He graduated with a BS in Biotechnology and MS in Bioanalytical Sciences from the University of Mumbai, and MS in Pharmaceutical Sciences from Northeastern University.
